865 related articles for article (PubMed ID: 29706556)
1. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free DNA: Applications in Different Diseases.
Ranucci R
Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genome-wide in cell free DNA methylation: progress and prospect.
Liu Z; Wang Z; Jia E; Ouyang T; Pan M; Lu J; Ge Q; Bai Y
Analyst; 2019 Oct; 144(20):5912-5922. PubMed ID: 31436778
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
7. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA diagnostics: current and emerging applications in oncology.
Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
[TBL] [Abstract][Full Text] [Related]
9. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
11. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
Tomasetti M; Amati M; Neuzil J; Santarelli L
Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
[TBL] [Abstract][Full Text] [Related]
12. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.
Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L
Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
Kahlert C
Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
[TBL] [Abstract][Full Text] [Related]
14. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free nucleic acids: characteristics and applications.
Pös O; Biró O; Szemes T; Nagy B
Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
[TBL] [Abstract][Full Text] [Related]
16. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
19. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
van der Pol Y; Mouliere F
Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
[TBL] [Abstract][Full Text] [Related]
20. Leveraging circulating microbial DNA for early cancer detection.
Kataria R; Shoaie S; Grigoriadis A; Wan JCM
Trends Cancer; 2023 Nov; 9(11):879-882. PubMed ID: 37659908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]